In clinical terms, TNF-α is probably associated with the severity of NAFLD; circulating TNF-α gradually increases from controls to patients with NAFL, and then, to patients with NASH. The gene discussed is TNF; the disease is metabolic dysfunction-associated steatotic liver disease.